Peptides for weight loss in Australia
Short answer: Semaglutide and tirzepatide are the registered, evidence-backed weight-loss peptides in Australia; retatrutide and AOD-9604 are unapproved and lawful only through a doctor's TGA SAS-B submission. All are prescription-only — expect a $99 telehealth consult, then $150 to $500 a month depending on the medicine.
Weight-loss peptides are the most searched and most misrepresented category in Australian peptide medicine. Here's what's actually registered, what needs a special-access pathway, what it costs, and what results the trial data supports.
Key points
- Semaglutide and tirzepatide are ARTG-registered and the only weight-loss peptides with strong Australian evidence.
- Retatrutide and AOD-9604 are unapproved — lawful only via a doctor's TGA SAS-B submission.
- Every injectable weight-loss peptide is Schedule 4: prescription-only, no exceptions.
- Expect $99 for the telehealth consult, then $150–$500 a month depending on the medicine and dose.
- Peptides work alongside protein intake, resistance training and sleep — not instead of them.
Two very different categories sit under one search term
When Australians search for weight-loss peptides they're usually mixing two things: registered GLP-1 medicines with large randomised trials behind them, and unapproved peptides sold on physique forums. The first group is mainstream medicine with a prescription pathway and a safety monitoring system. The second group is a regulatory exception pathway that a doctor can use when there's a clinical reason — not a shortcut around the rules.
How lawful access actually works
You complete a short eligibility check, then consult an AHPRA-registered doctor who reviews your weight history, comorbidities, medications, mental health and pregnancy plans. If a registered medicine fits, you get a standard script. If the doctor decides an unapproved peptide is clinically justified, they lodge SAS Category B naming you as the patient before an Australian licensed pharmacy dispenses. There is no lawful route that skips the prescriber.
Dose titration is what keeps you on treatment
Most people who abandon GLP-1 therapy do so because they escalated too fast and felt persistently nauseated. Standard practice is a low starting dose held for four weeks, then stepwise increases only if tolerated. Slower titration with adequate hydration, smaller meals and reduced fat load at dinner keeps far more people on treatment long enough to see results.
Protect your muscle while you lose fat
Rapid appetite suppression means many people under-eat protein. Aim for roughly 1.6 grams of protein per kilogram of target body weight and two to three resistance sessions a week. Without that, a meaningful share of the weight lost is lean mass, which lowers resting metabolic rate and makes maintenance harder later.
Monitoring your doctor should be doing
Baseline weight, waist, blood pressure, HbA1c or fasting glucose, lipids, and liver and kidney function where indicated. Reviews at four, twelve and twenty-six weeks looking at tolerability, response, muscle preservation and mood. A prescriber who won't schedule follow-up isn't managing a chronic condition, they're selling vials.
Warning signs of an unsafe provider
No consult before purchase, no AHPRA registration number you can verify on the public register, products shipped from overseas, 'research use only' labelling, guaranteed kilos lost, or pressure to buy multi-month bundles up front. Any one of these is enough to walk away.
Weight-loss peptides compared
| Peptide | TGA status | Typical monthly cost | Evidence for weight loss |
|---|---|---|---|
| Semaglutide | ARTG-registered | $250–$450 | Strong — ~15% average in trials |
| Tirzepatide | ARTG-registered | $300–$500 | Strong — ~20% average in trials |
| Retatrutide | Unapproved (SAS-B) | $250–$400 | Promising trial data, not yet registered |
| AOD-9604 | Unapproved (SAS-B) | $120–$200 | Weak — no clear benefit over placebo |
| Research-vial peptides | Unlawful supply | n/a | Unknown purity, no clinical oversight |
FAQs
- Which peptides are used for weight loss in Australia?
- The GLP-1 and dual/triple agonist class dominates: semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro) and, on an unapproved basis, retatrutide. AOD-9604 and fragment peptides are sometimes discussed for body composition, but the evidence for meaningful weight loss is weak compared with the GLP-1 class.
- Are weight-loss peptides legal in Australia?
- Yes, when prescribed. Semaglutide and tirzepatide are registered on the ARTG for specific indications. Unapproved options such as retatrutide can only be supplied lawfully after an AHPRA-registered doctor lodges a TGA Special Access Scheme Category B notification for you as a named patient.
- Can I buy weight-loss peptides online without a prescription?
- No. They are Schedule 4 prescription-only medicines. Sites selling 'research grade' semaglutide or retatrutide are operating outside therapeutic goods law, the vials aren't quality-tested for human use, and shipments are routinely seized at the Australian border.
- How much do weight-loss peptides cost in Australia?
- A $99 telehealth consult, then the medicine. Compounded or unapproved peptides typically run $150 to $350 a month; branded GLP-1s can be $250 to $500 a month when not PBS-subsidised. Most weight-management prescribing is not PBS-covered, so budget for the full private cost.
- How much weight can you actually lose?
- In registration trials, semaglutide averaged around 15 percent of body weight over 68 weeks and tirzepatide around 20 percent over 72 weeks, in both cases alongside diet and activity changes. Individual results vary widely, and weight typically returns if the medicine is stopped without a maintenance plan.
- What are the side effects?
- Nausea, reflux, constipation or diarrhoea, and reduced appetite are common early and usually settle as the dose is titrated. Less common but important: gallbladder problems, pancreatitis, dehydration and loss of lean mass if protein and resistance training are neglected. Your doctor screens for thyroid and pancreatic history before starting.
- Do I qualify for a weight-loss peptide?
- Generally a BMI of 30 or above, or 27 or above with a weight-related condition such as type 2 diabetes, hypertension, sleep apnoea or dyslipidaemia. The doctor also reviews eating patterns, mental health history, pregnancy plans, medications and prior attempts before deciding whether treatment is appropriate.
- Is AOD-9604 good for weight loss?
- AOD-9604 is a growth-hormone fragment marketed for fat metabolism, but human trials have not shown clinically meaningful weight loss compared with placebo. It is unapproved in Australia and only available through SAS-B. Any clinic presenting it as a GLP-1 alternative is overstating the evidence.
- How long until I see results?
- Appetite changes are often noticeable within the first two weeks, with measurable weight change usually from weeks four to eight as the dose escalates. Doctors typically review at 12 weeks and reconsider treatment if you haven't lost around 5 percent of starting weight.
- What happens when I stop?
- Appetite signalling returns to baseline and weight regain is common without a structured maintenance plan. That is why prescribing should come with nutrition, resistance-training and follow-up support rather than a vial and a goodbye.
- Can I get a script without seeing a doctor in person?
- Yes. Australian telehealth rules allow a video or phone consult with an AHPRA-registered doctor, and Australian compounding or retail pharmacies dispense to your address, usually within 24 to 48 hours of the script being issued.
Related reading
Medically reviewed by the PeptideDoctorAU Medical Review Panel — last reviewed 29 May 2026. See the panel.
Start lawfully — $99 telehealth consult
Free 5-minute pre-qualification. If suitable, you'll be matched with an AHPRA-registered Australian doctor — TGA SAS-B prescribing, Australian-compounded vial.
Start free assessment